StimLabs begins enrolment in Revita trial for diabetic foot ulcers

Designed as a wound covering, Revita is a placental membrane allograft intended for diabetic foot ulcers. Credit: rawpixel on Unsplash.



  • StimLabs begins enrolment in Revita trial for diabetic foot ulcers